MedTrace Logo

Valiant Thoracic Stent Graft With the Captivia Delivery System in the Treatment of Descending Thoracic Aortic Diseases (VALIANT CAPTIVIA France)

NCT01775046 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2022-02-09

No results posted yet for this study

Summary

The objective of this study is to assess the benefits of endovascular technique in terms of efficacy and safety of Valiant Thoracic Stent Graft with the Captivia Delivery System in the treatment of thoracic aortic disease, in a cohort of patients representative of the population treated under real-life conditions of use in France for up to 5 years.

Conditions

  • Aortic Aneurysm, Thoracic
  • Descending Thoracic Aortic Dissection
  • Penetrating Ulcer
  • Aorta Thoracic; Traumatic Rupture
  • Aortic Diseases

Interventions

DEVICE

DTA patients (Valiant)

Valiant Thoracic Stent Graft Implantation

Sponsors & Collaborators

  • Medtronic Cardiovascular

    lead INDUSTRY

Principal Investigators

  • Hervé Rousseau, MD, PhD · CHU Rangueil, 1 Avenue Jean Poulhes, TSA 50 032, 31059 TOULOUSE Cedex 9, FRANCE

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-23
Primary Completion
2021-06-21
Completion
2021-12-09

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01775046 on ClinicalTrials.gov